Princeton Global Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
OIAM
Princeton Global Asset Management's EW Position: Q2 2026 in Review
Princeton Global Asset Management increased its Edwards Lifesciences (EW) stake by 0.72% in Q2 2026, buying an estimated $419 and bringing the position to 695 shares worth $62.9K. The position accounts for 0.01% of the portfolio, ranked #335.
Princeton Global Asset Management first reported a position in EW in Q4 2019 and has held it in 21 quarters since. The position peaked at $94K in Q1 2022. 296 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Princeton Global Asset Management held 695 shares of Edwards Lifesciences worth $62.9K as of Q2 2026.
- Princeton Global Asset Management bought 5 Edwards Lifesciences shares in Q2 2026, an estimated $419.
- Edwards Lifesciences made up 0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #335 holding.
- Princeton Global Asset Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 21 quarters since.
- Princeton Global Asset Management's Edwards Lifesciences position peaked at $94K in Q1 2022.
- 296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.